Last reviewed · How we verify

Ganoderma lucidum — Competitive Intelligence Brief

Ganoderma lucidum (Ganoderma lucidum) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal/botanical immunomodulator. Area: Oncology, Immunology.

marketed Herbal/botanical immunomodulator Oncology, Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Ganoderma lucidum (Ganoderma lucidum) — Second Affiliated Hospital, School of Medicine, Zhejiang University. Ganoderma lucidum (reishi mushroom) modulates immune function and promotes apoptosis through polysaccharide and triterpene constituents that enhance natural killer cell activity and reduce inflammatory cytokines.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ganoderma lucidum TARGET Ganoderma lucidum Second Affiliated Hospital, School of Medicine, Zhejiang University marketed Herbal/botanical immunomodulator

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal/botanical immunomodulator class)

  1. Second Affiliated Hospital, School of Medicine, Zhejiang University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ganoderma lucidum — Competitive Intelligence Brief. https://druglandscape.com/ci/ganoderma-lucidum. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: